Global Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Region: Trend Forecast and Growth Opportunity
Global pharmacovigilance and drug safety software market will reach $432.3 million by 2031, growing by 7.3% annually over 2021-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions.
Highlighted with 82 tables and 92 figures, this 173-page report “Global Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmacovigilance and drug safety software market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Based on Functionality, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Ab Cube
Accenture PLC
ArisGlobal LLC
Cognizant Technology Solutions Corporation
Ennov Solutions Inc.
Extedo GmbH
Honeywell International Inc. (Sparta Systems Inc.)
IQVIA Inc.
Max Application
Oracle Corporation
Sarjen Systems Pvt. Ltd.
United BioSource LLC
Veeva Systems Inc.
Wipro Limited
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Highlighted with 82 tables and 92 figures, this 173-page report “Global Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmacovigilance and drug safety software market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
Based on Functionality, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Adverse Event Reporting Software
- Drug Safety Audits Software
- Issue Tracking Software
- Fully Integrated Software
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- On-premise Delivery
- On-demand Delivery
- Oncology
- Respiratory Disorders
- Cardiology
- Neurology
- Immunology
- Pain Management
- Other Indications
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Business Process Outsourcing Firms (BPOs)
- Other End Users
- North America (U.S., Canada, and Mexico)
- Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
- APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
- South America (Brazil, Chile, Argentina, Rest of South America)
- MEA (UAE?Saudi Arabia? South Africa and Rest of MEA)
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Ab Cube
Accenture PLC
ArisGlobal LLC
Cognizant Technology Solutions Corporation
Ennov Solutions Inc.
Extedo GmbH
Honeywell International Inc. (Sparta Systems Inc.)
IQVIA Inc.
Max Application
Oracle Corporation
Sarjen Systems Pvt. Ltd.
United BioSource LLC
Veeva Systems Inc.
Wipro Limited
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF GLOBAL MARKET BY FUNCTIONALITY
3.1 Market Overview by Functionality
3.2 Adverse Event Reporting Software
3.3 Drug Safety Audits Software
3.4 Issue Tracking Software
3.5 Fully Integrated Software
4 SEGMENTATION OF GLOBAL MARKET BY CLINICAL PHASE
4.1 Market Overview by Clinical Phase
4.2 Pre-clinical
4.3 Phase I
4.4 Phase II
4.5 Phase III
4.6 Phase IV
5 SEGMENTATION OF GLOBAL MARKET BY METHOD
5.1 Market Overview by Method
5.2 Spontaneous Reporting
5.3 Intensified ADR Reporting
5.4 Targeted Spontaneous Reporting
5.5 Cohort Event Monitoring
5.6 EHR Mining
6 SEGMENTATION OF GLOBAL MARKET BY DELIVERY MODE
6.1 Market Overview by Delivery Mode
6.2 On-premise Delivery
6.3 On-demand Delivery
7 SEGMENTATION OF GLOBAL MARKET BY INDICATION
7.1 Market Overview by Indication
7.2 Oncology
7.3 Respiratory Disorders
7.4 Cardiology
7.5 Neurology
7.6 Immunology
7.7 Pain Management
7.8 Other Indications
8 SEGMENTATION OF GLOBAL MARKET BY END USER
8.1 Market Overview by End User
8.2 Pharmaceutical and Biotechnology Companies
8.3 Contract Research Organizations (CROs)
8.4 Business Process Outsourcing Firms (BPOs)
8.5 Other End Users
9 SEGMENTATION OF GLOBAL MARKET BY REGION
9.1 Geographic Market Overview 2021-2031
9.2 North America Market 2021-2031 by Country
9.2.1 Overview of North America Market
9.2.2 U.S.
9.2.3 Canada
9.2.4 Mexico
9.3 European Market 2021-2031 by Country
9.3.1 Overview of European Market
9.3.2 Germany
9.3.3 U.K.
9.3.4 France
9.3.5 Spain
9.3.6 Italy
9.3.7 Netherlands
9.3.8 Rest of European Market
9.4 Asia-Pacific Market 2021-2031 by Country
9.4.1 Overview of Asia-Pacific Market
9.4.2 Japan
9.4.3 China
9.4.4 Australia
9.4.5 India
9.4.6 South Korea
9.4.7 Rest of APAC Region
9.5 South America Market 2021-2031 by Country
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America Market
9.6 MEA Market 2021-2031 by Country
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 Other National Markets
10 COMPETITIVE LANDSCAPE
10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Ab Cube
Accenture PLC
ArisGlobal LLC
Cognizant Technology Solutions Corporation
Ennov Solutions Inc.
Extedo GmbH
Honeywell International Inc. (Sparta Systems Inc.)
IQVIA Inc.
Max Application
Oracle Corporation
Sarjen Systems Pvt. Ltd.
United BioSource LLC
Veeva Systems Inc.
Wipro Limited
RELATED REPORTS
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF GLOBAL MARKET BY FUNCTIONALITY
3.1 Market Overview by Functionality
3.2 Adverse Event Reporting Software
3.3 Drug Safety Audits Software
3.4 Issue Tracking Software
3.5 Fully Integrated Software
4 SEGMENTATION OF GLOBAL MARKET BY CLINICAL PHASE
4.1 Market Overview by Clinical Phase
4.2 Pre-clinical
4.3 Phase I
4.4 Phase II
4.5 Phase III
4.6 Phase IV
5 SEGMENTATION OF GLOBAL MARKET BY METHOD
5.1 Market Overview by Method
5.2 Spontaneous Reporting
5.3 Intensified ADR Reporting
5.4 Targeted Spontaneous Reporting
5.5 Cohort Event Monitoring
5.6 EHR Mining
6 SEGMENTATION OF GLOBAL MARKET BY DELIVERY MODE
6.1 Market Overview by Delivery Mode
6.2 On-premise Delivery
6.3 On-demand Delivery
7 SEGMENTATION OF GLOBAL MARKET BY INDICATION
7.1 Market Overview by Indication
7.2 Oncology
7.3 Respiratory Disorders
7.4 Cardiology
7.5 Neurology
7.6 Immunology
7.7 Pain Management
7.8 Other Indications
8 SEGMENTATION OF GLOBAL MARKET BY END USER
8.1 Market Overview by End User
8.2 Pharmaceutical and Biotechnology Companies
8.3 Contract Research Organizations (CROs)
8.4 Business Process Outsourcing Firms (BPOs)
8.5 Other End Users
9 SEGMENTATION OF GLOBAL MARKET BY REGION
9.1 Geographic Market Overview 2021-2031
9.2 North America Market 2021-2031 by Country
9.2.1 Overview of North America Market
9.2.2 U.S.
9.2.3 Canada
9.2.4 Mexico
9.3 European Market 2021-2031 by Country
9.3.1 Overview of European Market
9.3.2 Germany
9.3.3 U.K.
9.3.4 France
9.3.5 Spain
9.3.6 Italy
9.3.7 Netherlands
9.3.8 Rest of European Market
9.4 Asia-Pacific Market 2021-2031 by Country
9.4.1 Overview of Asia-Pacific Market
9.4.2 Japan
9.4.3 China
9.4.4 Australia
9.4.5 India
9.4.6 South Korea
9.4.7 Rest of APAC Region
9.5 South America Market 2021-2031 by Country
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America Market
9.6 MEA Market 2021-2031 by Country
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 Other National Markets
10 COMPETITIVE LANDSCAPE
10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Ab Cube
Accenture PLC
ArisGlobal LLC
Cognizant Technology Solutions Corporation
Ennov Solutions Inc.
Extedo GmbH
Honeywell International Inc. (Sparta Systems Inc.)
IQVIA Inc.
Max Application
Oracle Corporation
Sarjen Systems Pvt. Ltd.
United BioSource LLC
Veeva Systems Inc.
Wipro Limited
RELATED REPORTS
LIST OF TABLES
Table 1. Snapshot of Global Pharmacovigilance and Drug Safety Software Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. Main Product Trends and Market Opportunities in Global Pharmacovigilance and Drug Safety Software Market
Table 5. Global Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 6. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, $ mn
Table 7. Global Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, $ mn
Table 8. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 9. Global Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, $ mn
Table 10. Global Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 11. Global Pharmacovigilance and Drug Safety Software Market by Region, 2021-2031, $ mn
Table 12. Leading National Pharmacovigilance and Drug Safety Software Market, 2021 and 2031, $ mn
Table 13. North America Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn
Table 14. U.S. Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 15. U.S. Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 16. U.S. Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 17. Canada Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 18. Canada Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 19. Canada Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 20. Mexico Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 21. Mexico Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 22. Mexico Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 23. Europe Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn
Table 24. Germany Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 25. Germany Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 26. Germany Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 27. U.K. Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 28. U.K. Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 29. U.K. Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 30. France Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 31. France Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 32. France Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 33. Spain Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 34. Spain Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 35. Spain Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 36. Italy Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 37. Italy Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 38. Italy Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 39. Netherlands Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 40. Netherlands Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 41. Netherlands Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 42. Pharmacovigilance and Drug Safety Software Market in Rest of Europe by Country, 2021-2031, $ mn
Table 43. APAC Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn
Table 44. Japan Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 45. Japan Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 46. Japan Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 47. China Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 48. China Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 49. China Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 50. Australia Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 51. Australia Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 52. Australia Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 53. India Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 54. India Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 55. India Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 56. South Korea Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 57. South Korea Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 58. South Korea Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 59. Pharmacovigilance and Drug Safety Software Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 60. South America Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn
Table 61. Argentina Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 62. Argentina Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 63. Argentina Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 64. Brazil Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 65. Brazil Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 66. Brazil Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 67. Chile Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 68. Chile Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 69. Chile Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 70. MEA Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn
Table 71. UAE Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 72. UAE Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 73. UAE Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 74. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 75. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 76. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 77. South Africa Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 78. South Africa Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 79. South Africa Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 80. Ab Cube: Company Snapshot
Table 81. Ab Cube: Business Segmentation
Table 82. Ab Cube: Product Portfolio
Table 1. Snapshot of Global Pharmacovigilance and Drug Safety Software Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. Main Product Trends and Market Opportunities in Global Pharmacovigilance and Drug Safety Software Market
Table 5. Global Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 6. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, $ mn
Table 7. Global Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, $ mn
Table 8. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 9. Global Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, $ mn
Table 10. Global Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 11. Global Pharmacovigilance and Drug Safety Software Market by Region, 2021-2031, $ mn
Table 12. Leading National Pharmacovigilance and Drug Safety Software Market, 2021 and 2031, $ mn
Table 13. North America Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn
Table 14. U.S. Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 15. U.S. Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 16. U.S. Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 17. Canada Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 18. Canada Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 19. Canada Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 20. Mexico Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 21. Mexico Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 22. Mexico Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 23. Europe Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn
Table 24. Germany Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 25. Germany Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 26. Germany Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 27. U.K. Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 28. U.K. Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 29. U.K. Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 30. France Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 31. France Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 32. France Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 33. Spain Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 34. Spain Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 35. Spain Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 36. Italy Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 37. Italy Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 38. Italy Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 39. Netherlands Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 40. Netherlands Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 41. Netherlands Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 42. Pharmacovigilance and Drug Safety Software Market in Rest of Europe by Country, 2021-2031, $ mn
Table 43. APAC Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn
Table 44. Japan Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 45. Japan Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 46. Japan Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 47. China Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 48. China Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 49. China Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 50. Australia Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 51. Australia Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 52. Australia Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 53. India Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 54. India Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 55. India Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 56. South Korea Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 57. South Korea Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 58. South Korea Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 59. Pharmacovigilance and Drug Safety Software Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 60. South America Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn
Table 61. Argentina Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 62. Argentina Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 63. Argentina Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 64. Brazil Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 65. Brazil Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 66. Brazil Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 67. Chile Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 68. Chile Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 69. Chile Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 70. MEA Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn
Table 71. UAE Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 72. UAE Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 73. UAE Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 74. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 75. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 76. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 77. South Africa Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn
Table 78. South Africa Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn
Table 79. South Africa Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn
Table 80. Ab Cube: Company Snapshot
Table 81. Ab Cube: Business Segmentation
Table 82. Ab Cube: Product Portfolio
LIST OF FIGURES
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Global Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Pharmacovigilance and Drug Safety Software Market
Figure 7. Percentage of Trial Participants by Country, 2015-2019
Figure 8. World Drug Discovery Market, 2019-2030, $ mn
Figure 9. Primary Restraints and Impact Factors of Global Pharmacovigilance and Drug Safety Software Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Fiver Forces Analysis of Global Pharmacovigilance and Drug Safety Software Market
Figure 12. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, % of Revenue
Figure 13. Global Addressable Market Cap in 2022-2031 by Functionality, Value ($ mn) and Share (%)
Figure 14. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Adverse Event Reporting Software, 2021-2031, $ mn
Figure 15. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Drug Safety Audits Software, 2021-2031, $ mn
Figure 16. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Issue Tracking Software, 2021-2031, $ mn
Figure 17. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Fully Integrated Software, 2021-2031, $ mn
Figure 18. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, % of Sales Revenue
Figure 19. Global Addressable Market Cap in 2022-2031 by Clinical Phase, Value ($ mn) and Share (%)
Figure 20. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Pre-clinical, 2021-2031, $ mn
Figure 21. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase I, 2021-2031, $ mn
Figure 22. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase II, 2021-2031, $ mn
Figure 23. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase III, 2021-2031, $ mn
Figure 24. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase IV, 2021-2031, $ mn
Figure 25. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, % of Sales Revenue
Figure 26. Global Addressable Market Cap in 2022-2031 by Method, Value ($ mn) and Share (%)
Figure 27. Global Pharmacovigilance and Drug Safety Software Market by Method: Spontaneous Reporting, 2021-2031, $ mn
Figure 28. Global Pharmacovigilance and Drug Safety Software Market by Method: Intensified ADR Reporting, 2021-2031, $ mn
Figure 29. Global Pharmacovigilance and Drug Safety Software Market by Method: Targeted Spontaneous Reporting, 2021-2031, $ mn
Figure 30. Global Pharmacovigilance and Drug Safety Software Market by Method: Cohort Event Monitoring, 2021-2031, $ mn
Figure 31. Global Pharmacovigilance and Drug Safety Software Market by Method: EHR Mining, 2021-2031, $ mn
Figure 32. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, % of Revenue
Figure 33. Global Addressable Market Cap in 2022-2031 by Delivery Mode, Value ($ mn) and Share (%)
Figure 34. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-premise Delivery, 2021-2031, $ mn
Figure 35. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-demand Delivery, 2021-2031, $ mn
Figure 36. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, % of Revenue
Figure 37. Global Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%)
Figure 38. Global Pharmacovigilance and Drug Safety Software Market by Indication: Oncology, 2021-2031, $ mn
Figure 39. Global Pharmacovigilance and Drug Safety Software Market by Indication: Respiratory Disorders, 2021-2031, $ mn
Figure 40. Global Pharmacovigilance and Drug Safety Software Market by Indication: Cardiology, 2021-2031, $ mn
Figure 41. Global Pharmacovigilance and Drug Safety Software Market by Indication: Neurology, 2021-2031, $ mn
Figure 42. Global Pharmacovigilance and Drug Safety Software Market by Indication: Immunology, 2021-2031, $ mn
Figure 43. Global Pharmacovigilance and Drug Safety Software Market by Indication: Pain Management, 2021-2031, $ mn
Figure 44. Global Pharmacovigilance and Drug Safety Software Market by Indication: Other Indications, 2021-2031, $ mn
Figure 45. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, % of Revenue
Figure 46. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 47. Global Pharmacovigilance and Drug Safety Software Market by End User: Pharmaceutical and Biotechnology Companies, 2021-2031, $ mn
Figure 48. Global Pharmacovigilance and Drug Safety Software Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn
Figure 49. Global Pharmacovigilance and Drug Safety Software Market by End User: Business Process Outsourcing Firms (BPOs), 2021-2031, $ mn
Figure 50. Global Pharmacovigilance and Drug Safety Software Market by End User: Other End Users, 2021-2031, $ mn
Figure 51. Global Market Snapshot by Region
Figure 52. Geographic Spread of Worldwide Pharmacovigilance and Drug Safety Software Market, 2021-2031, % of Sales Revenue
Figure 53. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)
Figure 54. North American Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn
Figure 55. Breakdown of North America Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue
Figure 56. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 57. U.S. Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn
Figure 58. Canada Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn
Figure 59. Pharmacovigilance and Drug Safety Software Market in Mexico, 2021-2031, $ mn
Figure 60. European Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn
Figure 61. Breakdown of European Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue
Figure 62. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 63. Pharmacovigilance and Drug Safety Software Market in Germany, 2021-2031, $ mn
Figure 64. Pharmacovigilance and Drug Safety Software Market in U.K., 2021-2031, $ mn
Figure 65. Pharmacovigilance and Drug Safety Software Market in France, 2021-2031, $ mn
Figure 66. Pharmacovigilance and Drug Safety Software Market in Spain, 2021-2031, $ mn
Figure 67. Pharmacovigilance and Drug Safety Software Market in Italy, 2021-2031, $ mn
Figure 68. Pharmacovigilance and Drug Safety Software Market in Netherlands, 2021-2031, $ mn
Figure 69. Pharmacovigilance and Drug Safety Software Market in Rest of Europe, 2021-2031, $ mn
Figure 70. Asia-Pacific Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn
Figure 71. Breakdown of APAC Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue
Figure 72. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 73. Pharmacovigilance and Drug Safety Software Market in Japan, 2021-2031, $ mn
Figure 74. Pharmacovigilance and Drug Safety Software Market in China, 2021-2031, $ mn
Figure 75. Pharmacovigilance and Drug Safety Software Market in Australia, 2021-2031, $ mn
Figure 76. Pharmacovigilance and Drug Safety Software Market in India, 2021-2031, $ mn
Figure 77. Pharmacovigilance and Drug Safety Software Market in South Korea, 2021-2031, $ mn
Figure 78. Pharmacovigilance and Drug Safety Software Market in Rest of APAC, 2021-2031, $ mn
Figure 79. South America Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn
Figure 80. Breakdown of South America Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue
Figure 81. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 82. Pharmacovigilance and Drug Safety Software Market in Argentina, 2021-2031, $ mn
Figure 83. Pharmacovigilance and Drug Safety Software Market in Brazil, 2021-2031, $ mn
Figure 84. Pharmacovigilance and Drug Safety Software Market in Chile, 2021-2031, $ mn
Figure 85. Pharmacovigilance and Drug Safety Software Market in Rest of South America, 2021-2031, $ mn
Figure 86. Pharmacovigilance and Drug Safety Software Market in Middle East and Africa (MEA), 2021-2031, $ mn
Figure 87. Breakdown of MEA Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue
Figure 88. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 89. Pharmacovigilance and Drug Safety Software Market in UAE, 2021-2031, $ mn
Figure 90. Pharmacovigilance and Drug Safety Software Market in Saudi Arabia, 2021-2031, $ mn
Figure 91. Pharmacovigilance and Drug Safety Software Market in South Africa, 2021-2031, $ mn
Figure 92. Growth Stage of Global Pharmacovigilance and Drug Safety Software Industry over the Forecast Period
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Global Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Pharmacovigilance and Drug Safety Software Market
Figure 7. Percentage of Trial Participants by Country, 2015-2019
Figure 8. World Drug Discovery Market, 2019-2030, $ mn
Figure 9. Primary Restraints and Impact Factors of Global Pharmacovigilance and Drug Safety Software Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Fiver Forces Analysis of Global Pharmacovigilance and Drug Safety Software Market
Figure 12. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, % of Revenue
Figure 13. Global Addressable Market Cap in 2022-2031 by Functionality, Value ($ mn) and Share (%)
Figure 14. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Adverse Event Reporting Software, 2021-2031, $ mn
Figure 15. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Drug Safety Audits Software, 2021-2031, $ mn
Figure 16. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Issue Tracking Software, 2021-2031, $ mn
Figure 17. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Fully Integrated Software, 2021-2031, $ mn
Figure 18. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, % of Sales Revenue
Figure 19. Global Addressable Market Cap in 2022-2031 by Clinical Phase, Value ($ mn) and Share (%)
Figure 20. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Pre-clinical, 2021-2031, $ mn
Figure 21. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase I, 2021-2031, $ mn
Figure 22. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase II, 2021-2031, $ mn
Figure 23. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase III, 2021-2031, $ mn
Figure 24. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase IV, 2021-2031, $ mn
Figure 25. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, % of Sales Revenue
Figure 26. Global Addressable Market Cap in 2022-2031 by Method, Value ($ mn) and Share (%)
Figure 27. Global Pharmacovigilance and Drug Safety Software Market by Method: Spontaneous Reporting, 2021-2031, $ mn
Figure 28. Global Pharmacovigilance and Drug Safety Software Market by Method: Intensified ADR Reporting, 2021-2031, $ mn
Figure 29. Global Pharmacovigilance and Drug Safety Software Market by Method: Targeted Spontaneous Reporting, 2021-2031, $ mn
Figure 30. Global Pharmacovigilance and Drug Safety Software Market by Method: Cohort Event Monitoring, 2021-2031, $ mn
Figure 31. Global Pharmacovigilance and Drug Safety Software Market by Method: EHR Mining, 2021-2031, $ mn
Figure 32. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, % of Revenue
Figure 33. Global Addressable Market Cap in 2022-2031 by Delivery Mode, Value ($ mn) and Share (%)
Figure 34. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-premise Delivery, 2021-2031, $ mn
Figure 35. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-demand Delivery, 2021-2031, $ mn
Figure 36. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, % of Revenue
Figure 37. Global Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%)
Figure 38. Global Pharmacovigilance and Drug Safety Software Market by Indication: Oncology, 2021-2031, $ mn
Figure 39. Global Pharmacovigilance and Drug Safety Software Market by Indication: Respiratory Disorders, 2021-2031, $ mn
Figure 40. Global Pharmacovigilance and Drug Safety Software Market by Indication: Cardiology, 2021-2031, $ mn
Figure 41. Global Pharmacovigilance and Drug Safety Software Market by Indication: Neurology, 2021-2031, $ mn
Figure 42. Global Pharmacovigilance and Drug Safety Software Market by Indication: Immunology, 2021-2031, $ mn
Figure 43. Global Pharmacovigilance and Drug Safety Software Market by Indication: Pain Management, 2021-2031, $ mn
Figure 44. Global Pharmacovigilance and Drug Safety Software Market by Indication: Other Indications, 2021-2031, $ mn
Figure 45. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, % of Revenue
Figure 46. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 47. Global Pharmacovigilance and Drug Safety Software Market by End User: Pharmaceutical and Biotechnology Companies, 2021-2031, $ mn
Figure 48. Global Pharmacovigilance and Drug Safety Software Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn
Figure 49. Global Pharmacovigilance and Drug Safety Software Market by End User: Business Process Outsourcing Firms (BPOs), 2021-2031, $ mn
Figure 50. Global Pharmacovigilance and Drug Safety Software Market by End User: Other End Users, 2021-2031, $ mn
Figure 51. Global Market Snapshot by Region
Figure 52. Geographic Spread of Worldwide Pharmacovigilance and Drug Safety Software Market, 2021-2031, % of Sales Revenue
Figure 53. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)
Figure 54. North American Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn
Figure 55. Breakdown of North America Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue
Figure 56. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 57. U.S. Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn
Figure 58. Canada Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn
Figure 59. Pharmacovigilance and Drug Safety Software Market in Mexico, 2021-2031, $ mn
Figure 60. European Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn
Figure 61. Breakdown of European Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue
Figure 62. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 63. Pharmacovigilance and Drug Safety Software Market in Germany, 2021-2031, $ mn
Figure 64. Pharmacovigilance and Drug Safety Software Market in U.K., 2021-2031, $ mn
Figure 65. Pharmacovigilance and Drug Safety Software Market in France, 2021-2031, $ mn
Figure 66. Pharmacovigilance and Drug Safety Software Market in Spain, 2021-2031, $ mn
Figure 67. Pharmacovigilance and Drug Safety Software Market in Italy, 2021-2031, $ mn
Figure 68. Pharmacovigilance and Drug Safety Software Market in Netherlands, 2021-2031, $ mn
Figure 69. Pharmacovigilance and Drug Safety Software Market in Rest of Europe, 2021-2031, $ mn
Figure 70. Asia-Pacific Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn
Figure 71. Breakdown of APAC Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue
Figure 72. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 73. Pharmacovigilance and Drug Safety Software Market in Japan, 2021-2031, $ mn
Figure 74. Pharmacovigilance and Drug Safety Software Market in China, 2021-2031, $ mn
Figure 75. Pharmacovigilance and Drug Safety Software Market in Australia, 2021-2031, $ mn
Figure 76. Pharmacovigilance and Drug Safety Software Market in India, 2021-2031, $ mn
Figure 77. Pharmacovigilance and Drug Safety Software Market in South Korea, 2021-2031, $ mn
Figure 78. Pharmacovigilance and Drug Safety Software Market in Rest of APAC, 2021-2031, $ mn
Figure 79. South America Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn
Figure 80. Breakdown of South America Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue
Figure 81. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 82. Pharmacovigilance and Drug Safety Software Market in Argentina, 2021-2031, $ mn
Figure 83. Pharmacovigilance and Drug Safety Software Market in Brazil, 2021-2031, $ mn
Figure 84. Pharmacovigilance and Drug Safety Software Market in Chile, 2021-2031, $ mn
Figure 85. Pharmacovigilance and Drug Safety Software Market in Rest of South America, 2021-2031, $ mn
Figure 86. Pharmacovigilance and Drug Safety Software Market in Middle East and Africa (MEA), 2021-2031, $ mn
Figure 87. Breakdown of MEA Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue
Figure 88. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 89. Pharmacovigilance and Drug Safety Software Market in UAE, 2021-2031, $ mn
Figure 90. Pharmacovigilance and Drug Safety Software Market in Saudi Arabia, 2021-2031, $ mn
Figure 91. Pharmacovigilance and Drug Safety Software Market in South Africa, 2021-2031, $ mn
Figure 92. Growth Stage of Global Pharmacovigilance and Drug Safety Software Industry over the Forecast Period
